D-0021-2024 Class II Terminated
FDA drug recall D-0021-2024 was initiated by Central Admixture Pharmacy Services Inc on Sep 21, 2023 and is designated Class II. Reason for recall: Lack of assurance of sterility: The recall status is terminated (terminated Mar 19, 2025). Affected quantity: 476, 50 mL Syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 11, 2023
- Initiation Date
- Sep 21, 2023
- Termination Date
- Mar 19, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 476, 50 mL Syringes
Product Description
fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3
Reason for Recall
Lack of assurance of sterility:
Distribution Pattern
Nationwide in the USA
Code Information
Lot:17-275464, Exp. 10/4/2023; 17-275850, Exp. 10/11/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0021-2024
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026